流行病学和亚洲心力衰竭的负担
Jiayu Feng1, Yuhui Zhang1, Jian Zhang1,2
1State Key Laboratory of Cardiovascular Disease, Heart Failure Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
JACC. Asia
|April 25, 2024
概括
心力衰竭 (HF) 是一个主要的全球健康问题. 本综述总结了亚洲的高温肺炎流行病学,强调了数据缺口和管理挑战,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 由于心力衰竭的高发病率,死亡率和经济负担,心力衰竭 (HF) 是一个重大的全球健康问题.
- 亚洲在HF预防和管理方面面临着独特的挑战,因为它拥有庞大,多样化的人口和复杂的医疗保健系统.
- 与西方国家相比,亚洲对HF的现有流行病学数据仍然有限.
研究的目的:
- 审查和综合亚洲心力衰竭的现有流行病学数据.
- 为了阐明发生,原因,风险因素,结果,和管理的HF跨不同的亚洲人群.
- 确定减少HF负担和改善该地区患者预后的关键见解.
主要方法:
- 对亚洲心力衰竭的流行病学研究的系统文献综述.
- 对有关HF流行,发病率,病因,风险因素和治疗结果的数据的分析.
- 综合发现,以确定趋势,挑战和未来研究和干预领域.
主要成果:
- 该审查强调了亚洲不同地区高频发病率和病因学的显著差异.
- 确定的关键风险因素包括高血压,糖尿病和特定的种族倾向.
- 数据表明,及时诊断,获得基于证据的治疗和低于最佳的患者结果存在挑战.
结论:
- 亚洲急需对心力衰竭进行全面的流行病学监测.
- 需要量身定制的预防和管理策略,以应对亚洲人群中HF的具体负担.
- 进一步的研究对于弥合数据缺口和改善亚洲心力衰竭患者的预后至关重要.
更多相关视频
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.4K
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.8K
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:26Heart Failure Drugs: Inotropic Agents
574
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574